EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 11th, 2016 • Flexion Therapeutics Inc • Pharmaceutical preparations • New York
THIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made and entered into effective as of July 25, 2014 (the “Effective Date”), by and between FLEXION THERAPEUTICS, INC., a Delaware corporation having a principal place of business at 10 Mall Road, Suite 301, Burlington, Massachusetts 01803 (“Flexion”) and SOUTHWEST RESEARCH INSTITUTE, a Texas nonprofit corporation having a principal place of business at 6220 Culebra Road, San Antonio, Texas 78238 (“SwRI”). Flexion and SwRI are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
SECOND AMENDMENT OF LEASESecond Amendment of Lease • March 11th, 2016 • Flexion Therapeutics Inc • Pharmaceutical preparations
AGREEMENT (“Second Amendment”) made this 15th day of December, 2015 by and between CIP II/RJK 10-20 BMR Owner, LLC, 55 Cambridge Street, Burlington, Massachusetts 01803 (hereinafter referred to as “Landlord”) and Flexion Therapeutics, Inc. (hereinafter referred to as “Tenant”).
